{
}
UBS has raised its target price for Thales from €160 to €330. Thales, a leading European manufacturer in electronic systems for aerospace, defense, and security, generates 53.3% of its sales from defense and security systems, 26.6% from aerospace, and 19.6% from digital identification solutions. The company also holds a 35% stake in Naval Group and has a diverse geographical sales distribution, with significant markets in France, Europe, and North America.
UBS believes the market is overly pessimistic about Fortescue, which saw an 11% drop in shares. The company's iron ore quality is improving with new mines like Iron Bridge, and UBS forecasts iron ore prices to stabilize between $90 and $100 per tonne over the next five years. Despite a slight reduction in share price targets, UBS maintains that the market's expectations for discounts on lower-grade iron ore are overstated.
UBS has upgraded Fortescue Metals Group Ltd from a Sell to a Neutral rating, adjusting the price target to AUD16.70 from AUD17.30 due to the stock trading below its previous target. Despite concerns over iron ore prices and discounts on lower-grade ore, UBS believes these worries are overstated, forecasting prices to stabilize between US$90 and US$100 per tonne over the next five years. The firm has also revised its earnings per share estimates downwards by 3-6% for fiscal years 2025 to 2027, reflecting a cautious outlook while noting Fortescue's strong financial health.
UBS has upgraded Fortescue Metals Group's stock rating to Neutral from Sell, while lowering the target price to AUD 16.70 from AUD 17.30, following a decline in share price. Analysts believe concerns over iron ore prices and discounts on low-grade ore are overstated, despite a slight increase in the discount rate to 16%. UBS has also revised its earnings per share estimates downwards by 3-6% for the financial years 2025 to 2027, reflecting a cautious outlook while acknowledging Fortescue's solid financial position.
The AUD/USD closed lower at 0.6272, influenced by a mixed Australian jobs report, US dollar short covering, and uncertainty surrounding China's stimulus. Key local drivers this week include the Monthly CPI data on Wednesday, with expectations of a slight decline in inflation, and speculation about US tariff specifics ahead of the April 2 deadline, which could support the Australian dollar. If the AUD/USD breaks below 0.6250/30, it may signal a retest of the 0.6087 low.
Morgan Stanley highlights key risks to the Australian sharemarket recovery, including a potential minority government that could slow spending and a shallow easing cycle from the RBA, with only one expected rate cut in May. The Aussie dollar faces pressure from US tariff threats, which could lead to price increases for consumer goods, while sentiment may be negatively impacted despite Australia's relatively modest exposure to tariffs.
Fortescue Ltd, an Australian company, operates in the global green technology, energy, and metals sectors. Its metals division focuses on iron ore exploration and production, with projects in the Pilbara and internationally, while the energy segment develops green electricity, hydrogen, and ammonia initiatives. Key projects include the Arizona Hydrogen project and the Iron Bridge operations.
Fortescue Ltd, an Australia-based global company, operates in green technology, energy, and metals, focusing on iron ore exploration and production. Its metals segment includes various projects in the Pilbara and globally, while the energy segment develops green electricity, hydrogen, and ammonia initiatives. Key projects include the Arizona Hydrogen project and the Iron Bridge operations.
UBS' Sydney trading floor, led by Michael Hendrie, handles $3 billion in daily transactions, accounting for 20% of the Australian Securities Exchange's turnover. In this high-pressure environment, traders are trained to perform under stress, likening their work to the intensity of a sports final where crucial decisions can lead to success or failure.
The global Cell Line Development Market is projected to grow at a CAGR of 12.13% from 2024 to 2031, driven by increasing demand in drug discovery and biopharmaceutical production. Key players include Lonza Group AG, Thermo Fisher Scientific Inc, and GE Healthcare, with significant regional markets in North America, Europe, and Asia-Pacific. The report offers insights into market trends, challenges, and opportunities, utilizing both qualitative and quantitative research methods.
AUS
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs raises thales target price reflecting strong market position and growth potential
10:08 24.03.2025
fortescue shares rebound as analysts predict iron ore price stabilization
09:23 24.03.2025
ubs upgrades fortescue stock rating to neutral and lowers target price
07:07 24.03.2025
ubs upgrades fortescue rating to neutral lowers target price to aud 16.70
06:37 24.03.2025
Australian dollar outlook amid US tariffs and upcoming CPI data
05:55 24.03.2025
key risks threaten australian sharemarket recovery amid economic uncertainties
Australian Dollar
United States Dollar
National Australia Bank Ltd
Commonwealth Bank of Australia
AUS
USA
Chris Weston
Joseph Capurso
04:29 24.03.2025
fortescue focuses on green technology and global energy initiatives
03:04 24.03.2025
fortescue selloff deemed excessive by UBS amid green energy focus
02:56 24.03.2025
inside the high stakes world of ubs sydney trading floor
19:02 23.03.2025
cell line development market projected to grow at 12.13 percent CAGR through 2031
Euro
United States Dollar
Thermo Fisher Scientific Inc.
Promega Corporation Corp.
Lonza Group AG
Corning Inc
GE HealthCare Technologies Inc.
NLD
FRA
ESP
MEX
GBR
ARE
ITA
IND
JPN
CAN
AUS
RUS
DEU
ZAF
KOR
SAU
BRA
USA
CHN
IDN
COL
ARG
Saikiran
Show more
19:14 22.03.2025
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Banking Regulations
Finance Mergers & Acquisitions
Global Financial Events
Retail and Consumer Goods
Central Bank Actions
GDP Growth & Recession Forecasts
CEO Changes
Global Trade Developments
Financial Scams and Security
Industry Mergers & Acquisitions
Market Analysis and Predictions
Inflation and Monetary Impact
Government Policies
Government Economic Policies
Supply Chain Management
Domestic Politics
Workplace Trends
Countries:
Companies:
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Tesla, Inc.
Apple Inc.
Bank of America Corporation
Barclays PLC
Wells Fargo & Company
Citigroup Inc.
Deutsche Bank Money Market PP
Morgan Stanley
Huawei Technologies CO. Ltd.
Lloyds Banking Group plc
Credit Suisse Strategic Income I
AXA SA
Safran SA
Banco Santander, S.A.
Novartis AG
Swiss Re AG
Beazley plc
UBS AG
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Japanese Yen
Indian Rupee
Russian Ruble
Canadian Dollar
Australian Dollar
United Arab Emirates Dirham
Saudi Riyal
Danish Krone
Offshore Chinese Yuan
Hong Kong Dollar
Mexican Peso
Indonesian Rupiah
South Korean Won
Malaysian Ringgit
Vietnamese Đồng
People: